share_log

B of A Securities Downgrades Outset Medical to Underperform, Lowers Price Target to $3

B of A Securities Downgrades Outset Medical to Underperform, Lowers Price Target to $3

B of A Securities将Extinal Medical的评级下调至表现不佳,目标股价下调至3
Benzinga ·  2023/10/13 08:19

B of A Securities analyst Travis Steed downgrades Outset Medical (NASDAQ:OM) from Buy to Underperform and lowers the price target from $32 to $3.

美国银行证券分析师特拉维斯·斯蒂德将纳斯达克(BofA:OM)的评级从买入下调至表现不佳,并将目标价从32美元下调至3美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发